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San-Huang-Xie-Xin-Tang (SHXXT), one of the most important traditional Chinese
medicinal formulas, is comprised by three herbal medicines, the rhizome of Rheum
officinale [or Rheum tanguticum (Polygonaceae) (Dahuang in Chinese)], the root of
Scutellaria baicalensis (Labiatae) (Huangqin in Chinese), and the rhizome of Coptis
chinensis (Ranunculaceae) (Huanglian in Chinese) in the ratios of 2:1:1 or 1:1:1. This
study is aimed to quantitate and qualify of SHXXT, by a rapid, convenient, and
effective HPLC-PDA approach associated with LC-MS technique. Of which method,
nine chosen major bioactive components in SHXXT, including aloe-emodin (Ale), baicalin
(Ba), berberine (Be), coptisine (Co), palmatine (Pa), resveratroloside (Res), rhein (Rh),
sennoside A (Se-A), and wogonin (Wo), were evaluated within 30min. The nine
chemical markers were monitored in a high sensitivity with a low detection limit of
0.01−0.55µg/mL and the correlation coefficient of the regression curve revealed a good
linearity with R2 > 0.99. Moreover, the extraction solution system and the HPLC elution
conditions were also optimized in the present study. This present developed protocol was
then successfully applied to quantify nine chemical markers of 10 SHXXT products from
eight Taiwanese TCM pharmaceutical companies. In quantitative results, Res was found
as themajor compound in SHXXT-1∼5 and 8with significantly higher amounts than those
in other products, indicating the products SHXXT-1∼5 and 8 may use R. tanguticum as
the raw material, which possessed a higher concentration of the bioactive composition
Res, instead of R. officinale. Simultaneously, Ale, Rh, and Wo were <2% in these 10
products. Different chemical profiles of commercial products indicated that, probably,
each product with the same named formula might be regarded as a sole medicine and
need to be investigated individually. Importantly, it is never too much to emphasize the
importance of quality control in TCM development.
Keywords: HPLC, San-Huang-Xie-Xin-Tang (SHXXT), Coptis chinensis, Rheum officinale, Rheum tanguticum,
Scutellaria baicalensis, quantification, quality control
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INTRODUCTION
In Asian countries, traditional Chinese medicines (TCM) are
widely used for improving the human health. Traditionally,
medicinal herbs are usually prescribed as the form of
combinatorial formula based on the traditional medicinal
philosophy, and most herbal medicines are administered as
decoctions (pronounced “Tang” in Chinese; Li S. L. et al., 2010).
However, the complicated processes of extract preparation
and problematic manufacture procedures cause difficulties
in the production of therapeutically equivalent medicines or
other convenient pharmaceutical dosage forms (Sheridan et al.,
2012). Although modernized extraction approach may help
overcome some problems, current clinical evidences are still
insufficient to ensure the therapeutic equivalence of herbal
decoctions, indicating that a single marker would not define
the quality of TCM (Sheridan et al., 2012). Importantly, the
chemical marker ingredients of TCM are commonly used to
standardize a herbal extract while the complex TCM formula
with various ingredients complicate the quality control.
Therefore, to develop an appropriate and efficient method in
quality control of the combinatorial formula of TCM is an
essential and critical issue, especially for the pharmaceutical
manufacturers.
San-Huang-Xie-Xin-Tang (SHXXT), one of the most
important traditional Chinese medicinal formulas, is comprised
by three herbal medicines, the rhizome of Rheum officinale Baill.
[or Rheum tanguticumMaxim. et Balf (Polygonaceae) (Dahuang
in Chinese)], the root of Scutellaria baicalensis Georgi. (Labiatae)
(Huangqin in Chinese), and the rhizome of Coptis chinensis
Franch. (Ranunculaceae) (Huanglian in Chinese) in the ratios of
2:1:1 or 1:1:1. According to the well-known and classical Chinese
medicine ancient books, jinkui yaolue (the golden chamber), the
use of SHXXT is to dry dampness, remove toxicity, and purge
heat. The indications are constipation, swelling, and pain of
body, especially in the eyes, yellow and greasy tongue coating
heat accumulation and choking sensation in chest, forceful and
rapid pulse, sores, boils, aphtha, and hypertension. In addition,
the traditional administration was to decoct the three materials
in water for oral dose to be taken twice. Nowadays, SHXXT
was produced and sold as Chinese patent medicine. Due to the
inconsistency of manufacturing process in different CGMP-TCM
biotechnical companies, the composition, quantity, and even the
dosage were all have to be based on the instruction sheet of each
product.
In the modern scientific literatures, the pharmacological
activities of SHXXT revealed its potential for symptoms of
gastrointestinal (GI) disorders, such as gastritis, gastric bleeding,
peptic ulcers, and abnormal GI motility (Kim et al., 2014;
Hwang et al., 2015), anti-hypertension (Tsai et al., 2008), anti-
inflammatory (Shih et al., 2007), neuroprotection (Lo et al.,
2012), anti-atherogenic (Wang Y. S. et al., 2011), anti-oxidant
Abbreviations: SHXXT, San-Huang-Xie-Xin-Tang; TCM, traditional Chinese
medicine; Ale, aloe-emodin; Ba, baicalin; Be, berberine; Co, coptisine; Pa,
palmatine; Res, resveratroloside; Rh, rhein; Se-A, sennoside A; Wo, wogonin;
CGMP, current good manufacturing practice.
(Shia et al., 2011), immunomodulatory (Li C. Y. et al., 2010),
anti-cancer (Cheng et al., 2008), gastrointestinal tract diseases
(Saegusa et al., 2003), and cardiovascular disease (Liou et al.,
2012). In the last decades, the phytochemical investigations
of herbal medicines found stilbenes and anthraquinones in R.
tanguticum, flavonoids in S. baicalensis, and alkaloids in C.
chinesis act as the major components and these compounds
were therefore chosen to be the biomarkers in quality control.
The structures of nine bioactive compounds, aloe-emodin (Ale),
baicalin (Ba), berberine (Be), coptisine (Co), palmatine (Pa),
resveratroloside (Res), rhein (Rh), sennoside A (Se-A), wogonin
(Wo), are shown in Figure 1.
Nowadays, diverse analytic methods were available for
SHXXT quantitation, including micellar electrokinetic
chromatography (MEKC) using silica capillary with UV
detector for analysis of a mixture of coptis alkaloids, scute
flavonoids, and rhubarb anthraquinones and bianthrones
(Chang and Sun, 2006), HPLC-UV techniques combined with
reverse-phase column eluted with organic solvent mixture
with different buffer solutions (sodium 1-pentanesulphate and
phosphorous acid) to detect several chemical markers in SHXXT
(Huang et al., 2006; Li and Xu, 2006; Li Y. et al., 2010) as well
as the UPLC-MS or LC-MS/MS instrument to separate and
identify the bioactive ingredients utilizing C18 column and the
mobile phase of acetonitrile mixed with ammonium acetate (Li
S. L. et al., 2010; Zan et al., 2011). These methods suffer from
several disadvantages, case by case, such as the limited sensitivity,
longer analysis time, expensive instrument, lower resolution, or
poor separation. To our knowledge, studies on either extensive
chemical comparison between commercial SHXXT products or
divergence quality analysis among R. officinale and R. tanguticum
containing formulas have not been reported.
To establish a convenient HPLC-based chemical profiling
method in order to obtain reliable and rapid separation of the
major bioactive constituents of SHXXT was quite an important
issue. After this work having been done, the connections
among quantities of the nine internal bioactive components
of commercial SHXXTs could directly be linked with the use
of dosage, estimated pharmacodynamic effects to consumers,
the predicted pharmacological mechanism and even based on
the SAR (structure and activity relationship). The optimized
HPLC analytical conditions were further successfully applied
to the quantitative analysis of the bioactive constituents of 10
commercial SHXXT products, including traditional decoctions
and dispensing granules.
MATERIALS AND METHODS
Chemical and Materials
All chemicals were of analytical grade. Aloe-emodin (Ale),
ammonium acetate, baicalin (Ba), berberine (Be), coptisine (Co),
palmatine (Pa), resveratroloside (Res), rhein (Rh), sennoside A
(Se-A), and wogonin (Wo) (≥98%) were purchased from Sigma-
Aldrich (Sigma-Aldrich Corp., St. Louis, MO, USA). Formic
acid and acetic acid (glacial, baker analyzed) was obtained from
J. T. Baker (JT Baker Chemical Co., Phillipsburg, NJ, USA).
Methanol and acetonitrile (HPLC grade) were purchased from
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FIGURE 1 | The structures of target anthraquinones, stilbenes, flavonoids, and alkaloids of SHXXT.
Merck (Merck KGaA, Darmstadt, Germany). Deionized water
(dd-H2O) was prepared using Milli-Q water purification system
(Millipore, Bedford, MA, USA), which was used to prepare the
buffers and related aqueous solutions. Nylon membrane filter
(0.22µm) was purchased from Millipore (Millipore, Bedford,
MA, USA).
HPLC-PDA Conditions
A Shimadzu HPLC system with LC-20AD pump, SIL-20HT
autosampler, SPD-M10A diode array detector was used. The
signals of the UV detector (230, 254, 280, 340, 430 nm) were
recorded and integrated by Shimadzu “Class VP” software. An
Agilent Poroshell 120 HPLC column (Agilent Technologies,
Inc., USA, 150 × 4.6mm I.D., 2.7µm) was utilized with the
mobile phase of acetonitrile and aqueous solution with 4mM
ammonium acetate (pH 3.5, adjusted by formic acid) in a
gradient system. The analysis started with 22% acetonitrile and
increase to 24% acetonitrile in 3min. Then acetonitrile was slowly
increased to 25% at 9min and increased to 28% acetonitrile at
10min. This percentage of acetonitrile was increased quickly to
49% acetonitrile to 14min and maintained for 7min. At 21–
25min, the mobile phase was changed to 52.5% acetonitrile
from 49% acetonitrile. Finally, acetonitrile was increased to 60%
acetonitrile at 30min. The flow rate used was 0.6mL/min and the
injection volume was 10µL. The analysis was detected at 254 nm
wavelength.
LC-MS Conditions
Qualitative LC-MS was performed using an Agilent 1100 HPLC
system (Agilent Technologies) coupled to a Finnigan LCQ Deca
XP Plus ion trap mass spectrometer (Thermo, Palo Alto, CA,
USA). Besides replacing the flow rate of 0.6 by 0.5mL/min,
the instrumentation and chromatographic condition of HPLC
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for LC-MS were the same as the described in Section HPLC-
PDA Conditions. The electrospray ionization (ESI) interface was
used for analytical detection. ESI was applied in the positive
and negative ionization modes and the capillary was held at a
potential of 3.0 kV. The cone voltage was set at 40V and the
ionization source was set to a temperature of 350◦C. Qualitative
analysis was performed by monitoring [M + H]+ or [M − H]−
for analytes in selected ion recording mode and the mass range
was set at m/z 100–1000, for identification purposes. All data
acquisition and processing were performed using Xcalibur 2.0
software (Thermo, Palo Alto, CA, USA).
HPLC Method Validation for Standard
Analysis
To establish a standard quality control protocol, a specific
calibration linear relationship was developed. The nine standards
(1.00 mg) were prepared with 1mL methanol, then filter by
Nylon membrane filter (0.22µm). The solution was further
FIGURE 2 | Effects of ammonium acetate and buffer pH on the migration of analytes (0.50 µg/mL each). HPLC profiles of (A) 5mM ammonium acetate and
buffer pH 3.5, (B) 4mM ammonium acetate and buffer pH 3.5, (C) 4mM ammonium acetate and buffer pH 2.5, (D) 4mM ammonium acetate and buffer pH 3.0, (E)
4mM ammonium acetate and buffer pH 4.0. Peaks: 1, resveratroloside (Res); 2, sennoside A (Se-A); 3, baicalin (Ba); 4, coptisine (Co); 5, palmatine (Pa); 6, berberine
(Be); 7, rhein (Rh); 8, aloe-emodin (Ale); 9, wogonin (Wo). HPLC condition in different ammonium acetate and buffer pH values: column, Agilent Poroshell 120 HPLC
column (Agilent Technologies, Inc., USA, 150× 4.6mm I.D., 2.7µm); mobile phase: an acetonitrile acetic-acetate buffer (4∼5mM; H2O, pH 2.5∼4), 2:98 (v/v); flow
rate, 0.6mL/min; injection volume, 10µL; UV detection: λ: 254 nm.
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analysis by HPLC. For the preparation of the calibration
curve, five standard concentrations of standard solutions (Ale:
0.075, 0.150, 0.300, 0.600, 1.200µg/mL; Ba: 5.0, 10.0, 20.0,
40.0, 80.0µg/mL; Be: 0.75, 1.50, 3.00, 6.00, 12.00µg/mL; Co:
0.15, 0.30, 0.60, 1.20, 2.40µg/mL; Pa: 0.25, 0.50, 1.00, 2.00,
4.00µg/mL; Res: 0.75, 1.50, 3.00, 6.00, 12.00µg/mL; Rh:
0.10, 0.20, 0.40, 0.80, 1.60µg/mL; Se-A: 0.40, 0.80, 1.60, 3.20,
6.40µg/mL; Wo: 0.0025, 0.0500, 0.1500, 0.3000, 0.6000µg/mL)
were prepared and quantitated by injecting each concentration
three times on three consecutive days (n = 3). The limit of
detection was determined by gradually decreasing concentration
of the standard until signal to noise (S/N) ratio was 3. LOD and
LOQ of nine standards are Ale: 0.01µg/mL and 0.03µg/mL, Ba:
0.18µg/mL and 0.55µg/mL, Be: 0.05µg/mL and 0.16µg/mL,
Co: 0.02µg/mL and 0.06µg/mL, Pa: 0.01µg/mL and
0.04µg/mL, Res: 0.02µg/mL and 0.06µg/mL, Rh: 0.01µg/mL
and 0.02µg/mL, Se-A: 0.03µg/mL and 0.11µg/mL, and Wo:
0.01µg/mL and 0.02µg/mL, respectively. The calibration curves
were successfully constructed using the peak area of the standard
(y axis) and the concentration of standard (µg/mL; x axis).
Three concentrations (µg/mL) in three replicate injections were
chosen to further investigate the intra- and inter-day precision
and accuracy analysis over a sequence of 3 days (n = 3). Certain
acceptance limits were developed for precision, linearity, and
accuracy. For precision, it was established to be <5% at RSD (%)
of the peak area of three replicate injections. The linearity limits
were set at correlation coefficient values exceeding 0.99. An
accuracy value between 95 and 105% was considered acceptable
for the intended purpose of this approach.
Preparation of SHXXT Samples
The prior-scale extraction product SHXXT-3 were chosen for the
evaluation of the optimization of the extraction approaches of
active components from commercial SHXXT products (SHXXT-
1∼10). Weighted 5.00mg SHXXT-3 and dissolved in different
methanol aqueous solutions (5, 50, and 100%) to obtain
0.50mg/mL solutions. The test solutions were ultrasonicated for
30min and the individual test solution was filtered with a 0.22-
µmMillipore filter (Nylon membrane filter), three samples were
prepared (10µL aliquot) for further HPLC analysis (n = 3).
Application of the Developed HPLC
Protocol for Commercial SHXXT Products
The prior-scale extraction products SHXXT-1∼3 (without
additives, such as excipients, antiadherents, etc.) were purchased
from one cGMP pharmaceutical company, and SHXXT-4∼10
from seven different cGMP pharmaceutical companies in
several different medicinal remedies (concentrated granules,
powders, tablets etc. with ca. 50% additives, such as excipients,
antiadherents, etc.). The herbal materials of those three Chinese
medicines must be imported from the most typical local region
of China, and each batch of them was selectively examined
and validated for authorizing the national criterion of Ministry
of Health and Welfare, Taiwan. The ratio of the active crude
FIGURE 3 | UV spectra of nine chemical analytes in SHXXT. (A) Resveratroloside (Res), (B) sennoside A (Se-A), (C) baicalin (Ba), (D) coptisine (Co),
(E) palmatine (Pa), (F) berberine (Be), (G) rhein (Rh), (H) aloe-emodin (Ale), (I) wogonin (Wo).
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TCM (Dahuang:Huangqin:Huanglian = 2:1:1 or 1:1:1), and the
additives were varied. It led to the quality examination of each
product is difficult to control.
To prepare the samples (SHXXT-1∼10) for analysis,
weighted 5.00mg samples and samples were dissolved in 50%
methanol aqueous solution (10mL). The sample solutions were
ultrasonicated for 30min, and centrifuged for 15min (3000 rpm).
The supernatant was filtered with a Nylon membrane filter
(0.22µm). One milliliter stock solution was diluted to 3mL and
a sample was taken from this diluted solution (10µL aliquot)
FIGURE 4 | Effects of five different UV detection wavelengths on the migration of analytes (0.50 µg/mL each). HPLC profiles of (A) 230 nm, (B) 254 nm,
(C) 280 nm, (D) 340 nm, (E) 430 nm were arranged.
Frontiers in Pharmacology | www.frontiersin.org 6 October 2016 | Volume 7 | Article 374
Wu et al. Quantification Approach for San-Huang-Xie-Tang
FIGURE 5 | Effects of five different gradient elution programs on the migration of analytes (0.50 µg/mL each). HPLC profiles of (A) Program I, (B) Program
II, (C) Program III, (D) Program IV, (E) Program V were demonstrated.
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FIGURE 6 | LC-MS spectra of nine chemical analytes in SHXXT. (A) resveratroloside—ESI(+), (B) sennoside A—ESI(–), (C) baicalin—ESI(–),
(D) coptisine—ESI(+), (E) palmatine—ESI(+), (F) berberine—ESI(+), (G) rhein—ESI(–), (H) aloe-emodin—ESI(–), and (I) wogonin—ESI(–) were shown.
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FIGURE 7 | HPLC profiles of SHXXT-3 in three different extraction methods, (A) 5% MeOH aqueous solution, (B) 50% MeOH aqueous solution, and
(C) 100% MeOH aqueous solution.
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for the subsequent HPLC analysis. All the analyses were carried
out and repeated for three times, and the data were recorded and
expressed in concentration (µg/mL) of standard as mean± SD.
RESULTS AND DISCUSSION
HPLC equipped with UV-Visible detector and diode
array detection (DAD) is the most common tool to
qualitative and quantitative analysis of TCM because of its
precision and accuracy. However, several parameters should be
evaluated and optimized including the mobile phase, detection
FIGURE 8 | Yields (%) of nine chemical markers isolated from SHXXT-3
by three different extraction methods. Method I: 5% MeOH aqueous
solution, Method II: 50% MeOH aqueous solution, Method III: 100% MeOH
aqueous solution.
wavelength, and gradient elution method based on the peak area
in the resulting HPLC chromatogram.
Previous report revealed that the best mobile phase solvents
for HPLC analysis of R. palmatum (Dahuang), S. Baicalensis
(Huangqin), C. chinensis (Huanglian), and SHXXT were
methanol and acetonitrile (Li S. L. et al., 2010; Boyle et al.,
2011; Wang G. Y. et al., 2011). For better stability, symmetric
peaks and good resolution, combination with 0.1−0.5% organic
acid, such as acetic acid, formic acid, trifluoroacetic acid, and
phosphoric acid, in aqueous phase was used to balance the effect
of the carboxylic group in Ba, Rh, and Se-A (Huang et al.,
2006; Ren et al., 2007; Li et al., 2011). Dissociation constants
between 3.4 and 3.6 were calculated using SPARC, an on-line
pKa calculator to predict the dissociation constant of those acidic
carboxylic group. Considering the broad application in industry
and convenient preparations, reversed C-18 stationary phase was
selected.
Optimization of HPLC
For optimization of the mobile phase, acetonitrile, and aqueous
solution with 4mM ammonium acetate, pH 3.5 (adjusted by
acetic acid), and pH 2.5, 3.0, 3.5, 4.0 (adjusted by formic acid), as
well as aqueous solution with 5mM ammonium acetate, pH 3.5
(adjusted by acetic acid) were examined in this study. The results
showed that the resolution of HPLC chromatogram while using
4 and 5mM ammonium acetate in pH 3.5 (adjusted by acetic
acid) were not optimal, because the peaks were broad and high
salt concentration (5mM) blocked the instrument, respectively.
Thus, the formic acid was used instead of acetic acid to adjust the
pH-value. In the Figure 2, different pH-values (2.5, 3.0, 3.5, and
4.0) adjusted by formic acid were tested, and the best resolution,
and minimum asymmetry values were observed at pH 3.5.
The structures of target anthraquinones, stilbenes, flavonoids,
and alkaloids are characterized by conjugated double bonds
and benzene rings, which implied the UV detectability. By
comparison of UV spectra with those of reference compounds,
the UV absorption of anthraquinones, flavonoids, stilbenes, and
alkaloids were detected at 250–280 nm (Wu et al., 2004; Kong
et al., 2009; Li et al., 2009; Li J. et al., 2010). The maxima
of UV absorptions for nine target compounds were co-eluted
and detected by photodiode array detector. Among them, the
anthraquinones of Se-A, Rh, and Ale were recorded at 223, 273,
262, and 256 nm, respectively. The UV spectra of Res (stilbenes)
had two absorbance maxima of 236 and 305 nm. The absorbance
maxima of Ba and Wo (flavonoids) were found at 276, 317,
and 275 nm. Otherwise, the maxima of UV absorptions of Co,
Pa, and Be (alkaloids) were shown at 266, 273, and 262 nm,
respectively (Figure 3). The UV spectra were compared at five
different wavelengths (230, 254, 280, 340, and 430 nm) in this
study (Figure 4). The UV results indicated that peak intensity of
nine target compounds obtained under wavelengths of 254 nm.
On the other hand, the nine target compounds can be detected in
this particular wavelength by HPLC analysis in simultaneously.
Therefore, 254 nm was selected as the suitable wavelengths.
However, the complicate ingredients in SHXXT led to
the difficulties in the determination of the qualitative and
quantitative analysis. The gradient elution of the mobile phase
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TABLE 1 | Regression analysis for the determination of nine analytes in intra-day and inter-day analysis#.
Compound (Peak No.) Retention time (min) Calibration range (µg/mL) Regression equation Coefficient of correlation (R2)
Resveratroloside (Res, 1) 4.83 0.75−12.00 Y = 13280.0X + 3543.1 0.9931
Sennoside A (Se-A, 2) 5.58 0.40−6.40 Y = 42404.0X + 3029.2 0.9971
Baicalin (Ba, 3) 10.91 5.00−80.00 Y = 37233.0X + 52341 0.9983
Coptisine (Co, 4) 18.42 0.10−2.40 Y = 55585.0X + 5375.3 0.9903
Palmatine (Pa, 5) 19.58 0.25−4.00 Y = 13039.0X + 2777.9 0.9916
Berberine (Be, 6) 21.13 0.75−12.00 Y = 73590.0X − 1532.2 0.9986
Rhein (Rh, 7) 23.81 0.10−1.60 Y = 99814.0X + 8013.8 0.9939
Aloe-emodin (Ale, 8) 24.37 0.075−1.200 Y = 75638.0X + 1326.2 0.9975
Wogonin (Wo, 9) 25.12 0.025−0.600 Y = 90308.0X + 2655.5 0.9954
#The regression equations for inter-day analysis were calculated from the assay values of the prepared standards on three different days (n = 3).
method was previously reported and referenced (Huang et al.,
2006; Li S. L. et al., 2010; Li Y. et al., 2010). Acetonitrile and 4mM
ammonium acetate in pH 3.5 (adjusted by formic acid) were
proposed and utilized in five different gradient elution programs
as follows:
Program I: Time (solution A %): tR 0.01−5min (5−10%),
5−6min (10−15%), 6−25min (15%), 25−35min (15−20%),
35−45min (20%), 45−55min (20−25%), 55−60min
(25−90%), 60−80min (90%).
Program II: Time (solution A %): tR 0.01−7min (20−22%),
7−10min (22−85%), 10−15min (85−95%), 15−23min
(95%), 23−25min (95−35%).
Program III: Time (solution A %): tR 0.01−5min (22−35%),
5−10min (35−65%), 10−16min (65−25%), 16−25min
(62−70%), 25−30min (70−35%).
Program IV: Time (solution A %): tR 0.01−3min (22−24%),
3−10min (24−27%), 10−14min (27−50%), 14−17min
(50−52%), 17−30min (52−60%).
Program V: Time (solution A %): tR 0.01−3min (22−24%),
3−9min (24−25%), 9−10min (25−58%), 10−13min
(28−49), 14−21min (49%), 21−25min (49−52.5%),
25−30min (52.5−60%).
As a result, ProgramV demonstrated themost well-defined peaks
of the target compounds (Figure 5). Thus, the optimum HPLC
condition is using the reversed phase HPLC, and a gradient
elution with 4mM ammonium acetate in pH 3.5 (adjusted by
formic acid) at 0.6mL/min which resulted in a good resolution
and short analysis time (30mins). The typical chromatogram
(Figure 5E) indicated nine target compounds in a time-flow
order: Res (tR 4.83min), Se-A (tR 5.58min), Ba (tR 10.91min),
Co (tR 18.42min), Pa (tR 19.58min), Be (tR 21.13min), Rh (tR
23.81min), Ale (tR 24.37min), andWo (tR 25.12min).
Mass Spectral Analysis of SHXXT
In order to confirm the purity of nine target compounds, the
qualitative protocol was performed using HPLC coupled to an
ion trap mass spectrometer and monitoring [M + H]+ or
[M − H]− for analytes in selected ion recording mode. The
same developed HPLC method for analysis of SHXXT was also
applied in LC-MS technique. Target compounds were prepared
TABLE 2 | LOD and LOQ of nine analytes#.
Compound (Peak No.) LOD (µg/mL) LOQ (µg/mL)
Resveratroloside (Res, 1) 0.02 0.06
Sennoside A (Se-A, 2) 0.03 0.11
Baicalin (Ba, 3) 0.18 0.55
Coptisine (Co, 4) 0.02 0.07
Palmatine (Pa, 5) 0.01 0.04
Berberine (Be, 6) 0.05 0.16
Rhein (Rh, 7) 0.01 0.02
Aloe-emodin (Ale, 8) 0.01 0.03
Wogonin (Wo, 9) 0.01 0.02
#LOD, limit of detection; LOQ, limit of quantification.
at 0.50mg/mL and injected to LC-MS for further analysis. The
LC-MS spectral was showed that four major types of compounds,
including anthraquinones, flavonoids, stilbenes, and alkaloids
were all detected and identified. Anthraquinones and flavonoids
were detected in negative mode, while stilbenes and alkaloids
were detected in positivemode (Figure 6). The target compounds
of Ale (m/z 269.21 [M − H]−), Ba (m/z 890.88 [2M − H]+),
Rh (m/z 862.99 [M − H]−), Se-A (m/z 861.19 [M − H]−),
and Wo (m/z 283.07 [M − H]−) detected in negative mode
and confirmed by comparison of UV/mass spectra with those
of reference compounds. Identically, Be (m/z 336.16 [M]+),
Co (m/z 320.22 [M]+), Pa (m/z 352.18 [M]+), and Res (m/z
390.97 [M]+) were observed in positive mode and confirmed
by comparison of UV/mass spectra with those of reference
compounds (Li S. L. et al., 2010). These results suggested that
the developed HPLC method is able to analyze the bioactive
compounds of SHXXT in a short time. Also, it revealed the good
resolution and reproducibility of this developed method.
Optimization of the Extraction of SHXXT
In order to concentrate the nine bioactive compounds in one
fraction and make sure each fraction must contain the nine
compounds, the samples of SHXXT-3 were extracted by 5, 50,
and 100%MeOH(aq) (Figure 7). In Figure 7, it indicated that the
50% MeOH(aq) extract of SHXXT processing higher amount of
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nine bioactive compounds, such asBa andBe (Figure 8). Baicalin
(Ba) is the most abundant flavonoid in SHXXT, which result is
similar to the previous report (Shih et al., 2007).
Calibration, Precision, and Accuracy
The quantitative analysis of target compounds was evaluated
and optimized. The quantitation range of each compound
was: Ale (0.075−1.200µg/mL), Ba (5.0−80.0µg/mL), Be
(0.75−12.00µg/mL), Co (0.15−2.40µg/mL), Pa (0.25−4.00µg/
mL), Res (0.75−12.00µg/mL), Rh (0.10−1.60µg/mL), Se-A
(0.40−6.40µg/mL), and Wo (0.025−0.600µg/mL; Table 1).
Five different concentrations of each compound were analyzed
and the peak area was calculated. The calibration graph was
established based on the peak area as the ordinate (Y) and
the concentration (µg/mL) of target compound as the abscissa
(X). Calculated linear regression equation of nine bioactive
compounds was as following: Ale (Y = 75638.0X + 1326.2), Ba
(Y = 37233.0X + 52341), Be (Y = 73590.0X − 1532.2), Co (Y
= 55585.0X + 5375.3), Pa (Y = 13039.0X + 2777.9), Res (Y =
13280.0X + 3543.1), Rh (Y = 99814.0X + 8013.8), Se-A (Y =
TABLE 3 | Precision and accuracy for the determination of nine analytes in intra-day and inter-day#.
Compound
(Peak No.)
Intra-day analysis (n = 3) Inter-day analysis (n = 3) Accuracy
(%)
Concentration
knowna (µg/mL)
Concentration found
(µg/mL)
R.S.D
(%)
Concentration knowna
(µg/mL)
Concentration found
(µg/mL)
R.S.D
(%)
RESVERATROLOSIDE (RES, 1)
3 3.11± 0.14 4.37 3.56 2.98± 0.01 0.34 −0.67
6 6.89± 0.62 9.01 14.78 6.53± 0.04 0.62 8.78
12 12.09± 0.25 2.10 0.72 12.17± 0.18 1.50 1.44
SENNOSIDE A (SE-A, 2)
1.6 1.49± 0.09 6.08 −6.67 1.70± 0.03 1.48 6.46
3.2 3.23± 0.02 0.47 0.83 3.15± 0.01 0.32 −1.56
6.4 6.38± 0.01 0.16 −0.31 6.46± 0.14 2.10 0.89
BAICALIN (BA, 3)
20 19.87± 0.12 0.58 −0.63 21.58± 0.14 0.66 7.29
40 41.17± 0.31 0.76 2.92 40.30± 0.67 1.66 0.76
80 80.71± 0.75 0.93 0.89 82.50± 0.02 0.03 2.57
COPTISINE (CO, 4)
0.6 0.52± 0.02 2.96 3.56 0.57± 0.01 1.75 5.00
1.2 1.31± 0.04 3.19 14.78 1.25± 0.03 2.44 4.44
2.4 2.36± 0.01 0.42 0.72 2.51± 0.12 4.71 4.72
PALMATINE (PA, 5)
1 0.90± 0.07 7.78 −6.67 1.07± 0.02 1.42 7.33
2 2.09± 0.02 0.73 0.83 2.09± 0.14 6.78 4.33
4 4.39± 0.30 6.83 −0.31 4.04± 0.06 1.51 1.00
BERBERINE (BE, 6)
3 3.25± 0.16 4.77 −0.63 3.06± 0.08 2.47 2.11
6 6.09± 0.16 2.58 2.92 6.20± 0.07 3.28 3.28
12 12.24± 0.02 0.17 0.89 12.08± 0.12 0.69 0.69
RHEIN (RH, 7)
0.4 0.41± 0.02 1.67 3.56 0.37± 0.01 1.55 −6.67
0.8 0.81± 0.02 0.83 14.78 0.81± 0.01 1.23 1.25
1.6 1.63± 0.01 1.87 0.72 1.60± 0.02 0.95 0.21
ALOE-EMODIN (ALE, 8)
0.3 0.29± 0.02 −4.44 −6.67 0.30± 0.01 1.95 −1.11
0.6 0.64± 0.02 7.22 0.83 0.62± 0.01 1.61 3.33
1.2 1.22± 0.01 1.67 −0.31 1.22± 0.02 1.64 1.67
WOGONIN (WO, 9)
0.15 0.17± 0.01 11.11 −0.63 0.13± 0.01 7.69 −13.33
0.3 0.32± 0.01 7.78 2.92 0.34± 0.02 4.45 14.44
0.6 0.58± 0.01 −2.78 0.89 0.61± 0.01 1.64 1.67
# Intra-day assay variance was validated with three known different concentrations of analytes at five intervals at a single day and inter-day assay variance was validated with three known
different concentrations of analytes during three successive days.
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42404.0X + 3029.2), andWo (Y = 90308.0X + 2655.5) with the
correlation coefficient (R2) reaching 0.99 (Table 1). The analysis
method was a triplet repeat (n = 3). The limit of detection (LOD)
of nine bioactive compounds was between 0.01 and 0.18µg/mL
and the limit of qualified (LOQ) of nine bioactive compounds was
between 0.02 and 0.55µg/mL (Table 2). This developed protocol
has enhanced the sensitivity of the previous research (LOD:
0.17−2.06µg/mL; Chang and Sun, 2006).
In inter- and intra-day analysis of this method, the peak
area at three different concentrations of each compound was
investigated. The results exhibited that the precision (relative
standard deviations, RSD) and accuracy (relative errors, RE)
of intra-day analysis were 0.16−7.78 and −0.31−14.78%,
respectively; However, in inter-day analysis were 0.03−9.69
and 0.21−14.44%, respectively (Table 3). The relative
recoveries of each compound was in the range of 94.6–106.8%
(Table 4).
Application
Ten SHXXT products (SHXXT-1∼10) were subjected to
HPLC analysis to determine the bioactive composition by
the developed method. The HPLC profiles for the sample
SHXXT-3 can be applied to all test products. Table 5 listed
TABLE 4 | Recovery test of nine analytes.
Compound (Peak No.) R.S.D (%) Recovery (%)
Concentration(µg/mL) Mean ± S.D.
RESVERATROLOSIDE (RES, 1)
6.0 2.59 103.41 ± 2.68
12.0 0.12 99.91 ± 0.12
SENNOSIDE A(SE-A, 2)
1.60 1.82 100.87 ± 1.84
3.20 3.77 100.59 ± 3.79
BAICALIN (BA, 3)
20.0 2.14 106.87 ± 2.29
40.0 0.96 100.58 ± 0.97
COPTISINE (CO, 4)
1.20 1.19 102.41 ± 1.22
2.40 5.52 101.33 ± 5.59
PALMATINE (PA, 5)
2.0 2.10 102.95 ± 2.16
4.0 3.01 102.58 ± 3.09
BERBERINE (BE, 6)
6.0 0.15 100.17 ± 0.15
12.0 0.59 100.86 ± 0.60
RHEIN (RH, 7)
0.80 5.46 94.66 ± 5.17
1.60 0.28 100.40 ± 0.28
ALOE-EMODIN (ALE, 8)
0.30 4.85 97.65 ± 4.73
1.20 4.10 97.58 ± 4.00
WOGONIN (WO, 9)
0.30 1.91 97.56 ± 1.86
0.60 1.85 98.82 ± 1.82 T
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the results of tested SHXXT products. The prior-scale
extraction products SHXXT-1∼3 showed higher chemical
contents owing to without additives. In SHXXT-1∼3, Res
(>56.59%) and Ba (>27.91%) were found as the major
compounds with significantly higher amounts twice than
those in other products from other pharmaceutical companies
(Table 5).
Moreover, the results showed that the contents of the chemical
components in different commercial SHXXT product extracts
were quite different. Interestingly, some products of companies
did not have Res. We found that the phenomenon was due
to the uses of different origins of Rheum, R. tanguticum, and
R. officinale. While the companies used the raw material R.
tanguticum, the formula will have Res. Res in Dahuang was rich
in SHXXT-1∼5 and 8 with 16.18−61.69% while Ba in Huangqin
was abundant in SHXXT-1∼3, 5, 9, and 10 with 10.28−39.97%.
For the compositions of Huanglian, Bewas abundant in SHXXT-
6 (26.38%), and Pa was enriched in SHXXT-4, 7, and 8 with
11.57−18.73%. Simultaneously, Rh, Ale, and Wo were <2% in
these 10 products.
Ten commercial products showed different chemical profiles
that indicated the importance to establish an easily and efficacy
of the quality control analysis method for SHXXT.
Moreover, to analyze the raw materials of SHXXT from
different regions to clarify the divergences for deciphering the
parameters on CMC (chemical manufacturing control) and GAP
(good agricultural practices) was also an indispensable job.
However, the samples of SHXXT in this study were directly
obtained from several CGMP-TCM biotechnical companies.
The exact comprising ratio and sources of the three materials,
rhizome of R. officinale, rhizome of R. tanguticum, root of
S. baicalensis, and rhizome of C. chinensis, were even some
kinds of know-how for them. The only information we
could know was that the Chinese medicinal materials must
had been imported from the most typical local region of
China.
Attributed to the aforementioned, the established QC method
in this work was created through the most representative
SHXXT products in the Chinese-speaking world. Even this
study was the first attempt for establishing a discriminative
and accurate QC method for SHXXT, the comprehensive
comparisons among those materials from different regions were
an imperative subject to be exhaustively researched in the near
future.
CONCLUSION
A simple, efficient and reliable HPLC-PDA method was
developed for the analysis of nine bioactive compounds in
SHXXT. The method was associated with LC-MS technique
for qualitative identification of active compounds in the tested
samples. The fine extraction solution was identified and the
optimized HPLC condition was validated in a good precision
and accuracy. Furthermore, this protocol was successfully
applied for the detection and quantification of 10 different
SHXXT products. Thus, the development of this method can
be applied to routine quality control analysis of SHXXT or
Dahuang/Huangqin/Huanglian containing TCM products.
What are the reasons for different chemical compositions
in producing SHXXT? We concluded the results owing to the
follows:
1. The different qualities and origins of materials, such as R.
tanguticum, and R. officinale, are applied to the manufacture.
2. Practically, in Taiwan, the government allows TCM
pharmaceutical companies to apply a TCM license to
manufacture according to the TCM literature. In the
literature, they may use the ratios of 2:1:1 or 1:1:1 for the
materials Dahuang:Huangqin:Huanglian to carry out the
products.
3. The variety of SHXXT products may be caused by adding
additives in different formulations. To overcome this problem,
we suggest that the manufacturers shall use the additives NOT
influence the composition of a formulated product.
4. Different factories may have at odds equipment and
processes in manufacturing. For examples, different heating
or evaporating equipment leads to inconsistent time
consumption in the concentration of extracts. Standard
chemical profiles lead to standard bioresponse. As results,
since different chemical profiles of several commercial
products were observed; therefore, probably, each same-
named formula product might be regarded as a sole medicine
and need to be investigated individually. We would like to
recall the importance of quality control in TCM development.
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